ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "neurology"

  • Abstract Number: 0844 • ACR Convergence 2024

    Effectiveness and Safety of the Recombinant Zoster Vaccine in Patients ≥18 Years of Age with Systemic Lupus Erythematosus or Multiple Sclerosis

    Sheryl Kluberg1, Sophie E. Mayer2, O’Mareen Spence3, Driss Oraichi4, Harry Seifert4, Omar Ali3, Huifeng Yun4, Andrew L. Simon5, Jenice S. Ko6, Caroline Hugh7, Meg Her7, Kathleen Shattuck7, Richard Platt8, Aziza Jamal-Allial9, Djeneba Audrey DJIBO10, Kimberly Daniels11, Qianli Ma12, Cheryl N McMahill-Walraven10, Rachel P. Ogilvie13, Kristin Palmsten14, Mano Selvan15, Najat Ziyadeh16, Alexis Ogdie17 and Michael George18, 1Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, 2Harvard Pilgrim Health Care Institute, Durham, 3GSK, Rockville, 4GSK, Rockville, MD, 5Harvard Pilgrim Healthcare Institute, Boston, MA, 6Harvard Pilgrim Health Care Ins􀆟tute, Boston, MA, 7Harvard Pilgrim Health Care Institute, Boston, MA, 8Harvard Pilgrim Health Care Institute / Harvard Medical School, Boston, MA, 9Carelon Research, Elevance Health, Newton, 10CVS Health, Blue Bell, 11Carelon Research, Elevance Health, Wilmington, 12Humana Healthcare Research, Inc., Louisville, 13Optum, Boston, MA, 14HealthPartners Institute, Minneapolis, 15Humana Healthcare Research, Sugar Land, Texas, 16Optum, Baltimore, MD, 17Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 18University of Pennsylvania, Philadelphia, PA

    Background/Purpose: The recombinant zoster vaccine (RZV) is US Food and Drug Administration-approved for the prevention of herpes zoster (HZ, shingles) in adults ≥50 years, and…
  • Abstract Number: 0926 • ACR Convergence 2024

    Macrophages and Nociceptor Neurons Form a Sentinel Unit Around Fenestrated Capillaries to Defend the Synovium from Systemic Challenges

    Tetsuo Hasegawa and Menna Clatworthy, University of Cambridge, Cambridge, United Kingdom

    Background/Purpose: A wide variety of systemic pathologies, including infectious and autoimmune diseases, are accompanied by joint pain or inflammation, often mediated by circulating immune complexes…
  • Abstract Number: 1092 • ACR Convergence 2024

    Chronic Kidney Disease Is Associated with Increased Glucose Uptake-associated Metabolic Activity of Visceral Adipose and Subcutaneous Adipose Tissue in Gout Patients

    Shunya Kaneshita1, Sho Fukui2, Soheil Niku3, KWANGHOON LEE4, Ernest Belezzuoli3, Robert Terkeltaub5 and Monica Guma6, 1UCSD, Miyazu city, Kyoto, Japan, 2Brigham and Women's Hospital, Brookline, MA, 3UCSD, La Jolla, 4UCSD, San Diego, CA, 5Retired, San Diego, CA, 6UCSD, La Jolla, CA

    Background/Purpose: Gout, a condition characterized by elevated uric acid levels, is linked to multiple complications, including coronary artery disease, hypertension, and type 2 diabetes mellitus.…
  • Abstract Number: 1093 • ACR Convergence 2024

    Risk of Dementia in Patients with Gout: Potential Impact of Survival Bias

    Joshua Baker1, Lindsay Helget2, chung-Chou Chang3, Bryant England2, Brian Coburn1, Harlan Sayles2, Punyasha Roul4 and Ted Mikuls2, 1University of Pennsylvania, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3University of Pittsburgh, Pittsburgh, PA, 4UNMC, Omaha, NE

    Background/Purpose: Prior studies reported a lower risk of dementia among patients with gout suggesting that hyperuricemia might play a neuroprotective role. However, risk estimates for…
  • Abstract Number: 1164 • ACR Convergence 2024

    IVIG Treatment Duration in Immune-mediated Necrotizing Myopathy and a Possible Association of Vacuolar Changes with Black/African American Female Patients

    Asim Mohamed1, Liron Caplan2 and Melissa Griffith3, 1PGY5, Aurora, CO, 2Rocky Mountain Regional VAMC, Aurora, CO, 3University of Colorado, Aurora, CO

    Background/Purpose: Immune Mediated Necrotizing Myopathy (IMNM) is a debilitating but understudied entity.  Correlations of demographic and clinical features with pathological findings remain underexplored.  In addition,…
  • Abstract Number: 1227 • ACR Convergence 2024

    Longitudinal Patterns of Fibromyalgia Phenotypes in Patients with Systemic Lupus Erythematosus

    Brooke Cohen1, Philip Carlucci2, Kelly Corbitt3, Mala Masson4, Amit Saxena5, H Michael Belmont5, Chung-E Tseng6, Rachel Wu7, Hamleini Martinez7, George Kenefati7, Lisa Doan7, Jing Wang8, Kamil Barbour9, Heather Gold7, Jill Buyon10 and Peter Izmirly11, 1NYU Langone, NYC, NY, 2New York University School of Medicine, New York, NY, 3University of Miami Miller School of Medicine, El Portal, FL, 4NYU Langone Medical Center- Division of Rheumatology, New York, NY, 5NYU School of Medicine, New York, NY, 6NYU Langone Health, Flushing, NY, 7NYU Langone Health, NYC, 8NYU Langone Health, NYC, NY, 9CDC, Alpharetta, GA, 10NYU Grossman School of Medicine, New York, NY, 11New York University Grossman School of Medicine, New York, NY

    Background/Purpose: Fibromyalgia (FM) is a common comorbidity in patients with systemic lupus erythematosus (SLE) and a major contributor to poor health related quality of life.…
  • Abstract Number: 1276 • ACR Convergence 2024

    Therapeutic Drug Monitoring (TDM) of Rituximab to Predict Early B-Cell Repopulation in Children

    Rana Alsulami1, Bindiya Chugani2, Joley Johnstone2, Ann Yeh2, Floris Loeff3, Linda Hiraki2, Andrea Knight4, Deborah Levy2 and Ruud Verstegen2, 1University of Toronto, Toronto, ON, Canada, 2The Hospital for Sick Children, Toronto, ON, Canada, 3Sanquin Diagnostic Services, Amsterdam, Netherlands, 4Division of Rheumatology, The Hospital for Sick Children; Neurosciences and Mental Health, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Rituximab is increasingly used in pediatric inflammatory diseases, with dosing extrapolated from adult data due to a lack of pediatric-specific pharmacokinetic (PK) information. Children…
  • Abstract Number: 1414 • ACR Convergence 2024

    Evidence-Based Guidelines for Sjögren’s Disease Peripheral Nervous System Manifestations

    Robert Fox1, Anahita Deboo2, Matthew Baker3, Stamatina Danielides4, Eduardo de Sousa5, Julie Frantsve Hawley6, Brent Goodman7, Katherine Hammitt6, Jennifer King8, Matt Makara6, Steven Mandel9, Ghaith Noaiseh10, Pantelis Pavlakis11, George Sarka12, Arun Varadhachary13, Daniel Wallace14, Robert Hal Scofield15, Nancy Carteron16 and Steven Carsons17, 1Rheumatology Clinic, San Diego, CA, 2Temple University, Philadelphia, 3Stanford University, Menlo Park, CA, 4Vcu, Glen Allen, VA, 5Mercy, Moore, OK, 6Sjogren's Foundation, Reston, VA, 7Mayo Clinic, Scottsdale, AZ, 8UCLA, Los Angeles, CA, 9Hofstra, Hempstead, 10University of Kansas Medical Center, Kansas City, KS, 11Hospital for Special Surgery, New York, NY, 12UCLA, Laguna Hills, CA, 13Washington University in St. Louis, St. Louis, MO, 14Cedars Sinai Medical Center, Studio City, CA, 15Oklahoma Medical Research Foundation, Oklahoma City, OK, 16University of California, Berkeley & San Francisco, Angwin, CA, 17NYU Long Island School of Medicine, Mineola, NY

    Background/Purpose: Peripheral Nervous System (PNS) manifestations occur frequently in Sjögren’s disease and can encompass mononeuropathy, polyneuropathy, and autonomic neuropathy. Guidance is needed for rheumatologists, neurologists,…
  • Abstract Number: 1420 • ACR Convergence 2024

    Alignment Between Rheumatology and Neurology of Nomenclature for Peripheral Nervous System Neuropathies

    Ghaith Noaiseh1, George Sarka2, Anahita Deboo3, Arun Varadhachary4, Robert Fox5, Matthew Baker6, Stamatina Danielides7, Eduardo de Sousa8, Julie Frantsve Hawley9, Brent Goodman10, Katherine Hammitt9, Jennifer King11, Steven Mandel12, Pantelis Pavlakis13, Daniel Wallace14, Robert Hal Scofield15, Nancy Carteron16 and Steven Carsons17, 1University of Kansas Medical Center, Kansas City, KS, 2UCLA, Laguna Hills, CA, 3Temple University, Philadelphia, 4Washington University in St. Louis, St. Louis, MO, 5Rheumatology Clinic, San Diego, CA, 6Stanford University, Menlo Park, CA, 7Vcu, Glen Allen, VA, 8Mercy, Moore, OK, 9Sjogren's Foundation, Reston, VA, 10Mayo Clinic, Scottsdale, AZ, 11UCLA, Los Angeles, CA, 12Hofstra, Hempstead, 13Hospital for Special Surgery, New York, NY, 14Cedars Sinai Medical Center, Studio City, CA, 15Oklahoma Medical Research Foundation, Oklahoma City, OK, 16University of California, Berkeley & San Francisco, Angwin, CA, 17NYU Long Island School of Medicine, Mineola, NY

    Background/Purpose: The Sjögren’s Foundation Clinical Practice Guidelines for Peripheral Nervous System (PNS) diagnosis, management and treatment in Sjögren’s brought to the fore a major issue…
  • Abstract Number: 2177 • ACR Convergence 2024

    CD59 Complement Membrane Regulator Deficiency: 12 Years of Clinical and Molecular Follow-up of 29 Patients

    Dror Mevorach, Netanel Karbian, Marian Zeibak and Adi Tabib, Hadassah-University Hospital, Jerusalem, Israel

    Background/Purpose: We have described in 2013, homozygous CD59-deficient children that manifest with recurrent peripheral neuropathy resembling Guillain-Barré syndrome (GBS), with hemolytic anemia and recurrent strokes.…
  • Abstract Number: 2420 • ACR Convergence 2024

    Blood Transcriptome Analysis Reveals Enhanced B Cell and Complement Cascade Signatures in Patients with Major Neuropsychiatric Systemic Lupus Erythematosus

    Dionysis Nikolopoulos1, George Sentis2, Jason Kitsos2, Panagiotis Garantziotis3, Noemin Kapsala2, antigoni Pieta2, Myrto Nikoloudaki4, Theodora Manolakou5, Sofia Flouda2, Ioannis Parodis6, Anastasia Filia2, George Bertsias7, Antonis Fanouriakis2 and Dimitrios Boumpas8, 1Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna, Stockholm, Sweden, 2National and Kapodistrian University of Athens, Athens, Greece, 3Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany, Erlangen, Germany, 4Rheumatology and Clinical Immunology, University of Crete School of Medicine, Heraklion, Greece, Heraklion, Greece, 5Karolinska Institutet, Stockholm, Sweden, 6Karolinska Institutet, Karolinska University Hospital; Örebro University, Solna, Sweden, 7Laboratory of Rheumatology, Autoimmunity and Inflammation. University Hospital, Rheumatology, Clinical Immunology, Heraklion, Greece, 84th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece, Athens, Greece

    Background/Purpose: The molecular basis of neuropsychiatric systemic lupus erythematosus (NPSLE) remains elusive because of clinical heterogenicity, the complexity of pathophysiologic mechanisms involved and limited access…
  • Abstract Number: 2461 • ACR Convergence 2024

    Prevalence and Impact of Peripheral Neuropathy in SSc: A Frequent and Disabling Manifestation in SSc, and a Potential Surrogate Marker for Autonomic Neuropathy

    Begonya Alcacer-Pitarch1, marco di battista2, Anthony C. Redmond3, Anne-Maree Keenan4, Stefano Di Donato5, Francesco Del Galdo3 and Maya H. Buch6, 1Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom, 2Rheumatology Unit, University of Pisa, Pisa., Pisa., Italy, 3University of Leeds, Leeds, United Kingdom, 4School of Healthcare, university of leeds, leeds, United Kingdom, 5Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK, Leeds, United Kingdom, 6Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

    Background/Purpose: SSc patients have high disability and low quality of life (QoL), driven partially by poor physical function (PF), Gastro Intestinal (GI) problems, digital ulcers…
  • Abstract Number: 2481 • ACR Convergence 2024

    General, Nervous System, Eye, and Skin Involvement in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis

    Rula A. Hajj-Ali1, Duvuru Geetha2, Raashid Luqmani3, Christian Pagnoux4, Darcy Trimpe5, David Jayne6 and Peter Merkel7, and ADVOCATE Study Group, 1Cleveland Clinic, Cleveland, OH, 2Johns Hopkins University, Baltimore, MD, 3University of Oxford, Abingdon, United Kingdom, 4Mount Sinai Hospital, Toronto, ON, Canada, 5Amgen Inc., Thousand Oaks, CA, 6University of Cambridge, Cambridge, United Kingdom, 7University of Pennsylvania, Philadelphia, PA

    Background/Purpose: The most common types of ANCA-associated vasculitis, granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), can affect a range of organs, including the kidneys,…
  • Abstract Number: 0311 • ACR Convergence 2024

    Investigation of Sarcoidosis-associated Neuropathy: Challenges with Diagnosis of Small Fiber Neuropathy

    Kristen Caldwell1, Sindhuja Koppu1, Kelly Gwathmey1, Aamer Syed1, Jordana Kron1, Thomas Iden1 and Huzaefah Syed2, 1Virginia Commonwealth University, Richmond, VA, 2Virginia Commonwealth University Medical Center, Richmond, VA

    Background/Purpose: Small fiber neuropathy (SFN) is an underrecognized complication of sarcoidosis which can significantly impair individuals’ physical functioning and quality of life. Diagnosis includes both…
  • Abstract Number: PP09 • ACR Convergence 2024

    Finding the Balance: Regaining My Strength While Living with Sjögren’s & POTS

    Robert Fearon, Sjögren's Foundation, Reston, VA

    Background/Purpose: Like many suffering from autoimmune diseases, my diagnosis was not straightforward and took nearly 13 years to get answers. I first started experiencing an…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology